Representative Matters
Representative Life Sciences Matters
- Sale of Medical Device Intellectual Property Assets – Lead counsel in a multi-million-dollar sale of intellectual property assets for a medical device company, managing transaction structure, cross-border and tax issues, drafting and negotiating asset purchase and ancillary agreements, and securing a license-back arrangement to preserve ongoing research rights for the inventor.
- Biotechnology Licensing Transactions – Represented a biotechnology company in out-licensing patented formulation processes and devices to universities in the United States and Europe, negotiating and drafting patent licenses, development agreements, material transfer agreements, and related intellectual property arrangements to maximize commercial opportunities across multiple fields of use.
- Pharmaceutical Research and Development Collaborations – Negotiated and drafted research and development agreements between biotechnology, pharmaceutical, and academic partners relating to DNA-based animal health and food-industry technologies, including intellectual property ownership, licensing, and commercialization provisions.
- Pharmaceutical Manufacturing Agreements – Advised pharmaceutical companies on the negotiation and drafting of manufacturing and supply agreements, including quality control, testing, regulatory compliance, and risk allocation provisions.
- White-Label Manufacturing for Wellness and Cannabis Products – Represented manufacturers of wellness and recreational cannabis products in negotiating white-label production agreements, addressing quality assurance, product testing, recalls, labeling requirements, and regulatory compliance.
- Product Labeling, Advertising, and Claims Compliance – Provided strategic regulatory and brand-protection advice for pharmaceutical, natural health, wellness, cosmetic, and cannabis products, including review of labeling, packaging, advertising, websites, and promotional materials for compliance with U.S. and Canadian regulatory requirements.
- Cannabis Supply and Distribution Agreements – Advised licensed cannabis producers on domestic and international supply arrangements, including agreements for the cultivation, manufacture, export, and sale of medicinal and recreational cannabis products in European markets.
- Health Technology and Digital Health Transactions – Served as technology and intellectual property counsel to one of Canada’s largest public health authorities, negotiating technology licenses, software agreements, outsourcing arrangements, and innovative healthcare technology procurements.
- Life Sciences Data Licensing and Data-Sharing Agreements – Represented multinational agriscience companies in negotiating data-sharing agreements, software licenses, and intellectual property arrangements involving agricultural, crop-growth, fertilizer, and herbicide technologies.
- Material Transfer Agreements (MTAs) – Drafted and negotiated material transfer agreements involving biological materials, compounds, and formulations for pre-clinical testing and pharmaceutical research, balancing intellectual property protection with collaboration and commercialization objectives.
- Intellectual Property Commercialization and Technology Transfer – Advised life sciences, biotechnology, medical device, pharmaceutical, public health, agriscience, animal health, and wellness companies on the protection, licensing, transfer, development, and commercialization of intellectual property assets and related technologies.
- Strategic Life Sciences Regulatory Counseling – Worked directly with C-suite executives, general counsel, regulatory, and marketing teams to develop commercialization, licensing, branding, regulatory compliance, and risk-management strategies across the pharmaceutical, biotechnology, medical device, wellness, cannabis, public health, agriscience, and animal health sectors.